CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report

CMO growth hampered by innovator approvals from mega cap pharma, yet contract clinical and recombinant vector manufacturing growing in demand

Read more ›››

New Greenphire Data Indicates Clinical Trial Industry's Swift Rebound; Patient Enrollment Reaches Pre-Pandemic Levels

New Greenphire Data Indicates Clinical Trial Industry's Swift Rebound; Patient Enrollment Reaches Pre-Pandemic Levels Research spotlights the need for technological …

Read more ›››

CPhI Worldwide to return in 2021: Milan venue to play host to global pharma as Italy gears up for strong growth

2021 will bring global pharma community back together in person to drive business growth

Read more ›››

ATMPS advanced therapy blockchain platform has successful testing with NHS partners

New ‘blockchain ecosystem’ has potential to track, from vein-to-vein, advanced therapies 19 October, 2020: ATMPS Ltd – a spinout of …

Read more ›››

Approvals of COVID-19 biologics will put huge pressure on large-scale bioprocessing networks, according to CPhI Annual Report

Tightening of bio-manufacturing capacity expected to occur after 2024, whilst Europe forecast to equal North America in total capacity

Read more ›››

Sirio Europe invest in advanced manufacturing and green technologies at Brandenburg site

Brandenburg, Germany, 15 October 2020: Sirio Europe – the leading European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO), …

Read more ›››

CPhI South East Asia rescheduled for 2021

CPhI South East Asia – organised by Informa Markets – has been rescheduled to May 18-20, 2021 to give the ASEAN pharma community …

Read more ›››

CPhI Announces 17th Annual CPhI Pharma Awards Winners

The winners of the 17th annual CPhI Pharma Awards, Powered by Informa Pharma Intelligence, were announced at its first-ever virtual ceremony …

Read more ›››

CPhI Annual Report Part 2: Generics transforming with innovator-like products, and wide-spread adoption of telemedicine in USA by 2025

Voice-driven AI used to transmit patient information in home and hospital, with newly genericized small molecules protected from encroachment by …

Read more ›››

Marshall Pillay joins OKRA

Cambridge, UK, October 5th 2020 - OKRA is thrilled to announce the appointment of Marshall Pillay as VP Commercial - Europe and International. Starting today, …

Read more ›››

The AI Productivity Game in Pharma

The pharmaceutical business is one of the riskiest industries to venture into. Drug discovery is an artisanal process where a …

Read more ›››

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events

Organisers have also confirmed the launch of a virtual CPhI China and enhanced online platforms to keep the industry connected …

Read more ›››